Division of Nursing, Midwifery and Social Work, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom.
J Adolesc Young Adult Oncol. 2024 Feb;13(1):40-54. doi: 10.1089/jayao.2023.0048. Epub 2023 Jun 12.
To identify and evaluate patient-reported outcome measures (PROMs) for assessing survivorship-related concepts for adolescent and young adult (AYA) survivors of central nervous system (CNS) tumors. We searched five electronic databases. Two researchers independently screened all titles for inclusion and used consensus-based standards for the selection of health measurement instruments (COSMIN) guidance to grade the quality of evidence for each measurement property. Four studies met eligibility criteria: single-item pain thermometer; single-item fatigue thermometer; 37-item pediatric functional assessment of cancer therapy-brain tumor survivors, measuring quality of life; and 12-item Perceived Barriers Scale to assess barriers to employment. The Perceived Barrier Scale showed high-quality evidence for internal consistency and moderate quality evidence for construct and structural validity. Evidence for the measurement properties of the other PROMs was low-to-moderate quality. We found one PROM with sufficient evidence for good measurement properties to support its use. This warrants development and evaluation of further PROMs to inform ongoing supportive care for this population. The Perceived Barriers Scale is sufficiently validated and could be considered to guide support for AYA survivors of CNS tumors to achieve their employment goals.
为了识别和评估用于评估中枢神经系统 (CNS) 肿瘤青少年和年轻成人 (AYA) 幸存者相关生存概念的患者报告结局测量指标 (PROM)。我们搜索了五个电子数据库。两名研究人员独立筛选所有标题以进行纳入,并使用健康测量仪器选择的共识标准 (COSMIN) 指南对每项测量特性的证据质量进行分级。四项研究符合入选标准:单项疼痛温度计;单项疲劳温度计;37 项儿童癌症治疗-脑肿瘤幸存者的功能评估,用于衡量生活质量;以及 12 项评估就业障碍的感知障碍量表。感知障碍量表在内部一致性方面具有高质量证据,在结构和结构有效性方面具有中等质量证据。其他 PROM 的测量特性的证据质量较低至中等。我们发现一种 PROM 具有足够的证据支持其使用,以证明其具有良好的测量特性。这需要开发和评估更多的 PROM,以告知这一人群正在进行的支持性护理。感知障碍量表具有足够的验证,可被认为是指导 CNS 肿瘤 AYA 幸存者实现其就业目标的支持工具。